IOVANCE BIOTHERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $166.9M | $106.7M |
| FY2017 | — | $145.5M | $145.4M |
| FY2018 | — | $466.2M | $82.2M |
| FY2019 | — | $299.0M | $14.0M |
| FY2020 | — | $656.5M | $67.3M |
| FY2021 | — | $621.7M | $78.2M |
| FY2022 | — | $499.6M | $231.7M |
| FY2023 | — | $584.6M | $114.9M |
| FY2024 | — | $710.4M | $115.7M |
| FY2025 | — | $698.6M | $163.1M |